BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.

Pashtoon Murtaza KasiSakti ChakrabartiSarah SawyerMichael KrainockAndrew PoklepovicGeorge AnsstasMinu ManinderMeenakshi MalhotraJoe EnsorLing GaoZeynep ErogluSascha EllersPaul BillingsAngel RodriguezAlexey Aleshin

Published in: BMJ open (2022)

NCT04761783.

Keyphrases

randomized controlled trial
study protocol
clinical trial
circulating tumor
double blind